biological drug

biological drug, Total:25 items.

The international standard classification for "biological drug" includes: Medical Sciences and health care facilities in general .

The Chinese standard classification for "biological drug" includes: Sanitation in general .

Yunnan Provincial Standard of the People's Republic of China

DB5308/T 40-2017 Evaluation Standards for Green Biopharmaceutical Enterprises

Professional Standard - Agriculture

1033药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sunitinib
551药典化学药和生物制品卷-2010 Chapter VII Urinary System Drugs Section III Special Drugs for Urinary System 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist doxazosin mesylate
1024药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Nimotuzumab
554药典化学药和生物制品卷-2010 Chapter 7 Urinary System Drugs Section 3 Special Urinary System Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (3) Natural herbal medicine Pushitai Tablets
1772药典化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Newborns 1. Pharmacokinetic characteristics of newborns
1030药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Lapatinib
1031药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Gefitinib
553药典化学药和生物制品卷-2010 Chapter VII Urinary System Drugs Section III Urinary System Special Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (2) 5α-reductase inhibitor finasteride
1026药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Cetuximab
1029药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Imatinib
1774药典化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Neonates 3. Precautions for Antibiotics Use in Neonates
555药典化学药和生物制品卷-2010 Chapter Seven Urinary System Drugs Section Three Urinary System Special Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (3) Natural herbal medicine Pygeum africanum extract*
552药典化学药和生物制品卷-2010 Chapter VII Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist tamsulosin hydrochloride
1027药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Bevacizumab
1023药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Trastuzumab
1773药典化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Neonates 2. Calculation of Drug Dose in Neonates
550药典化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist terazosin hydrochloride
1034药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Ubenimex
1028药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sorafenib
549药典化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist alfuzosin hydrochloride
1775药典化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application for Newborns 4. Common Drugs for Neonatal Resuscitation and Reference Doses of Commonly Used Antibiotics
1032药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Erlotinib

Professional Standard - Hygiene

WS/T 248-2005 Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria

Professional Standard - Environmental Protection

HJ 1256-2022 Self-monitoring technology guidelines for pollution sources ―Pharmaceutical industry Chinese traditional medicine category, biological pharmaceutical products category, chemical pharmaceutics preparations category